Grant: Doctoral Research Award - PA: Biomedical/Clinical HIV/AIDS Research
University of Toronto
$44,000.00
The impact of HIV co-infection and complement factor 5a on the dysregulated immune response in placental malaria
EF 2008-09
Résumé
Every year, fifty million pregnant women are at risk of malaria. Pregnancy malaria (PM) results in one third of all low-birth weight infants in Africa. During PM, red blood cells containing malaria parasites bind to the surface of the placenta. In an attempt to clear the infection, the mother's immune system initiates an inflammatory response; however, this often results in placental injury and poor fetal outcomes. HIV co-infection has been shown to increase the risk of adverse pregnancy outcomes in PM, but little is known about the underlying reasons for these disease interactions. The objective of this proposal is to understand the mechanisms underlying PM and determine why outcomes are worsened in the face of HIV-1 co-infection.
Recently, investigators implicated C5a, a protein involved in early immune responses, in a model of recurrent abortions. Our research group found elevated levels of C5a in PM in Kenya. We now plan to investigate the role of C5a in the adverse pregnancy outcomes observed in malaria infection and HIV-malaria co-infection. To do this, we will: I) Characterize the maternal immune cells present during PM and investigate how these cells react to C5a; II) Examine C5a levels in pregnant women with and without PM and HIV from large-scale studies with banked samples in an attempt to define the significance of C5a in mediating poor fetal outcomes; III) Use an animal model and genetic tools to describe how C5a changes the immune response. These studies will enable us to identify critical components of the immune response that are dysregulated in PM, and may open the door to treatment options. An estimated 360,000 or more infant deaths in Africa could be avoided if malaria-associated low-birth weight were prevented. Moreover, by obtaining a greater understanding of the immune response to PM, we may also gain insight into the maternal immune response to infectious agents that affect pregnant women in developed countries, e.g. influenza.
Programme
Doctoral Research Award - PA: Biomedical/Clinical HIV/AIDS Research
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
178070
Name
Conroy Andrea
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
The impact of HIV co-infection and complement factor 5a on the dysregulated immune response in placental malaria
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$44,000
Cihrequipment2
$0
Programname2
Doctoral Research Award - PA: Biomedical/Clinical HIV/AIDS Research
Keyworddelim
Animal Modelling Of Placental Malaria; Biomarkers Of Disease Pathogenesis; Ex Vivo Analysis Of Placental Immune Status; Functional Characterization Of Cells In The Placenta; Hiv Malaria Co-Infections; Intervention Trials Using Animal Models; Measure Levels Of Inflammatory Proteins In The Placenta; Phenotypic Characterization Of Cells In The Placenta; Placental Malaria Pathophysiology
Abstract
Every year, fifty million pregnant women are at risk of malaria. Pregnancy malaria (PM) results in one third of all low-birth weight infants in Africa. During PM, red blood cells containing malaria parasites bind to the surface of the placenta. In an attempt to clear the infection, the mother's immune system initiates an inflammatory response; however, this often results in placental injury and poor fetal outcomes. HIV co-infection has been shown to increase the risk of adverse pregnancy outcomes in PM, but little is known about the underlying reasons for these disease interactions. The objective of this proposal is to understand the mechanisms underlying PM and determine why outcomes are worsened in the face of HIV-1 co-infection.
Recently, investigators implicated C5a, a protein involved in early immune responses, in a model of recurrent abortions. Our research group found elevated levels of C5a in PM in Kenya. We now plan to investigate the role of C5a in the adverse pregnancy outcomes observed in malaria infection and HIV-malaria co-infection. To do this, we will: I) Characterize the maternal immune cells present during PM and investigate how these cells react to C5a; II) Examine C5a levels in pregnant women with and without PM and HIV from large-scale studies with banked samples in an attempt to define the significance of C5a in mediating poor fetal outcomes; III) Use an animal model and genetic tools to describe how C5a changes the immune response. These studies will enable us to identify critical components of the immune response that are dysregulated in PM, and may open the door to treatment options. An estimated 360,000 or more infant deaths in Africa could be avoided if malaria-associated low-birth weight were prevented. Moreover, by obtaining a greater understanding of the immune response to PM, we may also gain insight into the maternal immune response to infectious agents that affect pregnant women in developed countries, e.g. influenza.
Competitiondate
200810
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Conroy, Andrea
Approvedterm
2 ans 0 mois
Cihrcontribution2
Science Policy 4~ $44,000~ $0~